Sanofi (Beijing) Pharmaceuticals Co., LTD. NO. 7 XING SHENG STREET, BEIJING EC ONOMIC & TECHNOLOGICAL DEVELOPMENT AREA, B CN | Buyer Report — Panjiva
MENU

Supply Chain Intelligence about:

Sanofi (Beijing) Pharmaceuticals Co.

Company profile   China

See Sanofi (Beijing) Pharmaceuticals Co.'s products and suppliers

Thousands of companies like you use Panjiva to research suppliers and competitors.

Easy access to trade data

Cleaned and organized India shipments

3 India shipments available for Sanofi (Beijing) Pharmaceuticals Co.
Date Data Source Supplier Details
2018-09-29 India Export Shipments
SANOFI INDIA LIMITED
MEDICAL DEVICE, ALLSTAR (REUSABLE INSULIN DELIVERY DEVICE) PURPLE
2018-09-29 India Export Shipments
SANOFI INDIA LIMITED
MEDICAL DEVICE, ALLSTAR (REUSABLE INSULIN DELIVERY DEVICE) PURPLE
2019-03-13 India Export Shipments
SANOFI INDIA LIMITED
MEDICAL DEVICE, ALLSTAR (REUSABLE INSULIN DELIVERY DEVICE) PURPLE
Shipment data shows what products a company is trading and more. Learn more

Explore trading relationships hidden in supply chain data

Contact information for Sanofi (Beijing) Pharmaceuticals Co.

 
Address
LTD. NO. 7 XING SHENG STREET, BEIJING EC ONOMIC & TECHNOLOGICAL DEVELOPMENT AREA, B CN
 
 

Sample Bill of Lading

3 shipment records available

Bill of Lading Number
7935946
HS Code
90183100
Goods Described
MEDICAL DEVICE, ALLSTAR (REUSABLE INSULIN DELIVERY DEVICE) PURPLE
Item Quantity
24335.0
Item Quantity Unit
PAC
Item Value, FOB (INR)
11337600.0
Departure Date
2018-09-29
Shipper
Sanofi India Ltd.
Shipper (Original Format)
SANOFI INDIA LIMITED
Consignee
Sanofi (Beijing) Pharmaceuticals Co.
Consignee (Original Format)
SANOFI (BEIJING) PHARMACEUTICALS CO
Port of Unlading
Tianjin (CN)
Port of Lading
Nhava Sheva (Jawaharlal Nehru) (IN)
Shipment Destination
China
Transport Method
Maritime
Item Number
1
Value of Goods (USD)
156326.783867631851059296
Value of Goods, FOB (INR)
11337600.0

Recent Panjiva Research about Sanofi (Beijing) Pharmaceuticals Co.

20161202-insulin-us

Novo and Lilly Face Tough Growth in Diabetes, Trade Data Shows

The global prevalence of diabetes is growing, but can be a tough sector for pharmaceutical companies to make money in as recent results from Novo Nordisk and Eli Lilly demonstrate. Panjiva data shows that U.S. imports of insulin and related equipment fell 15% in the third quarter in dollar ter... Read more →